Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?: The RIPCORD Study

Background—The use of coronary angiography (CA) for diagnosis and management of chest pain (CP) has several flaws. The assessment of coronary artery disease using fractional flow reserve (FFR) is a well-validated technique for describing lesion-level ischemia and improves clinical outcome in the context of percutaneous coronary intervention. The impact of routine FFR at the time of diagnostic CA on patient management has not been determined. Methods and Results—Two hundred patients with stable CP underwent CA for clinical indications. The supervising cardiologist (S.C.) made a management plan based on CA (optimal medical therapy alone, percutaneous coronary intervention, coronary artery bypass grafting, or more information required) and also recorded which stenoses were significant. An interventional cardiologist then measured FFR in all patent coronary arteries of stentable diameter (≥2.25 mm). S.C. was then asked to make a second management plan when FFR results were disclosed. Overall, after disclosure of FFR data, management plan based on CA alone was changed in 26% of patients, and the number and localization of functional stenoses changed in 32%. Specifically, of 72 cases in which optimal medical therapy was recommended after CA, 9 (13%) were actually referred for revascularization with FFR data. By contrast, of 89 cases in whom management plan was optimal medical therapy based on FFR, revascularization would have been recommended in 25 (28%) based on CA. Conclusions—Routine measurement of FFR at CA has important influence both on which coronary arteries have significant stenoses and on patient management. These findings could have important implications for clinical practice. Clinical Trial Registration—URL: http://www.clinicaltrial.gov. Unique identifier: NCT01070771.

[1]  A. Briggs,et al.  Fractional flow reserve versus angiography in guiding management to optimize outcomes in non–ST-elevation myocardial infarction (FAMOUS-NSTEMI): Rationale and design of a randomized controlled clinical trial , 2013, American heart journal.

[2]  N. Curzen,et al.  Should ischemia be the main target in selecting a percutaneous coronary intervention strategy? , 2013, Expert review of cardiovascular therapy.

[3]  Jing Li,et al.  Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practice. , 2013, European heart journal.

[4]  Eun Bo Shim,et al.  Visual-functional mismatch between coronary angiography and fractional flow reserve. , 2012, JACC. Cardiovascular interventions.

[5]  Nikola Jagic,et al.  Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. , 2012, The New England journal of medicine.

[6]  U. Siebert,et al.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.

[7]  H. Hemingway,et al.  Incremental prognostic value of the exercise electrocardiogram in the initial assessment of patients with suspected angina: cohort study , 2008, BMJ : British Medical Journal.

[8]  Guido Germano,et al.  Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2008, Circulation.

[9]  William Wijns,et al.  Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. , 2007, Journal of the American College of Cardiology.

[10]  S. Ghiringhelli,et al.  Performing versus deferring coronary angioplasty based on functional evaluation of vessel stenosis by pressure measurements: a clinical outcome study , 2006, Journal of cardiovascular medicine.

[11]  D. Walters,et al.  Measurement of myocardial fractional flow reserve is a cost-effective way to identify coronary artery lesions of indeterminate severity that warrant revascularisation. , 2005, Heart, lung & circulation.

[12]  M. Leesar,et al.  Thirty-month outcome after fractional flow reserve-guided versus conventional multivessel percutaneous coronary intervention. , 2005, The American journal of cardiology.

[13]  Y. Aude,et al.  How to prevent unnecessary coronary interventions: identifying lesions responsible for ischemia in the cath lab , 2003, Current opinion in cardiology.

[14]  D. Berman,et al.  Comparison of the Short‐Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion Single Photon Emission Computed Tomography , 2003, Circulation.

[15]  William Wijns,et al.  Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis: A Randomized Trial , 2001, Circulation.

[16]  C. Di Mario,et al.  Intravascular ultrasound criteria for the assessment of the functional significance of intermediate coronary artery stenoses and comparison with fractional flow reserve. , 2001, The American journal of cardiology.

[17]  J. Koolen,et al.  Coronary Pressure Measurement to Assess the Hemodynamic Significance of Serial Stenoses Within One Coronary Artery: Validation in Humans , 2000, Circulation.

[18]  L. Leape,et al.  Effect of variability in the interpretation of coronary angiograms on the appropriateness of use of coronary revascularization procedures. , 2000, American heart journal.

[19]  A. Oktay,et al.  Correlation of myocardial fractional flow reserve with thallium-201 SPECT imaging in intermediate-severity coronary artery lesions. , 1999, The Journal of invasive cardiology.

[20]  K. Fox,et al.  Women with chest pain: is exercise testing worthwhile? , 1996, Heart.

[21]  F. Tristani,et al.  Left main coronary artery stenosis: angiographic determination. , 1983, Circulation.

[22]  R. Dinsmore,et al.  Interobserver Variability in Coronary Angiography , 1976, Circulation.

[23]  Volkmar Falk,et al.  Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I , 2022 .